Real-world effectiveness of upadacitinib in moderate-to-severe atopic dermatitis (AD): Results from cross-sectional analyses of the CorEvitas AD Registry

被引：0

作者：

Silverberg, Jonathan, I ^{[1
]}

Gooderham, Melinda ^{[2
]}

Calimlim, Brian ^{[3
]}

Grada, Ayman ^{[3
]}

Maldonado, Yolanda Munoz ^{[4
]}

Li, Alvin ^{[4
]}

Crabtree, Margaux M. ^{[4
]}

Simpson, Eric ^{[5
]}

机构：

[1] George Washington Univ, Sch Med & Hlth Sci, Dept Dermatol, Washington, DC USA

[2] Queens Univ, SKiN Ctr Dermatol, Prob Med Res, Peterborough, ON, Canada

[3] AbbVie Inc, N Chicago, IL USA

[4] CorEvitas, Waltham, MA USA

[5] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR USA

来源：

关键词：

atopic dermatitis; moderate-to-severe; patient-reported outcomes; upadacitinib; CorEvitas AD registry (formerly Corrona AD registry);

D O I：

10.1093/bjd/ljad498.030

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

525

引用

页码：II27 / II28

页数：2